{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:30Z","timestamp":1753876290267,"version":"3.41.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Infective endocarditis (IE) is a serious infection with high morbidity and mortality that involves the endocardial lining of the heart. Most cases of IE are due to bacteria although other atypical micro-organisms can also be involved. Procalcitonin (PCT) is a biomarker that is used in the diagnosis of bacterial infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We present the case of a 54-year-old patient with bacterial endocarditis who has been regularly visiting his cardiologist for follow-up on a mitral valve prolapse and moderate mitral regurgitation (MR) for the last 11 years. During his last visit, transthoracic echocardiography (TTE) showed a previously non-existent structure on the posterior mitral valve leaflet with severe MR. Blood cultures were positive for Streptococcus viridans. On admission, he had elevated levels of PCT and C-reactive protein which returned to normal values after 4 weeks of intravenous antibiotic therapy. His follow-up blood cultures, taken after normalization of PCT, did not show bacterial growth; however, on TTE he had severe mitral regurgitation and a persistent vegetation which had slightly increased in size after completion of the full antibiotic course. He was referred for mitral valve replacement surgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Normalization of procalcitonin levels may correlate with negative blood cultures in cases of IE with residual vegetations. The optimal time for surgery in such patients is difficult to define but even in circumstances with less infective organisms such as S. viridans and late in the course of the disease residual vegetations remain a serious risk factor for embolic events. Randomized controlled clinical trials are needed in order to have better recommendations with solid evidence regarding prophylaxis and treatment in IE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytab312","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T18:20:11Z","timestamp":1627928411000},"source":"Crossref","is-referenced-by-count":0,"title":["Normal procalcitonin, C-reactive protein, and negative blood cultures in infective endocarditis with a massive residual vegetation: a case report"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-354X","authenticated-orcid":false,"given":"Dzhem","family":"Farandzha","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Hospital Lozenetz, Kozyak 1, Sofia, 1407, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-2324","authenticated-orcid":false,"given":"Petranka","family":"Shikerova","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Lozenetz, Kozyak 1, Sofia, 1407, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-2544","authenticated-orcid":false,"given":"Gergana","family":"Lazarova","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Lozenetz, Kozyak 1, Sofia, 1407, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-0835","authenticated-orcid":false,"given":"Dobri","family":"Hazarbasanov","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Lozenetz, Kozyak 1, Sofia, 1407, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"2021092112130699000_ytab312-B1","first-page":"1621","volume-title":"Hurst\u2019s the Heart","author":"Fuster","year":"2017","edition":"14th ed."},{"key":"2021092112130699000_ytab312-B2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"key":"2021092112130699000_ytab312-B3","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"2021092112130699000_ytab312-B4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jacc.2013.07.029","article-title":"Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort","volume":"62","author":"Hubert","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2021092112130699000_ytab312-B5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.ihj.2018.05.001","article-title":"Baseline C-reactive protein levels and prognosis in patients with infective endocarditis: a prospective cohort study","volume":"70 Suppl 3","author":"Mohanan","year":"2018","journal-title":"Indian Heart J"},{"key":"2021092112130699000_ytab312-B6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajem.2013.03.008","article-title":"Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis","volume":"31","author":"Yu","year":"2013","journal-title":"Am J Emerg Med"},{"key":"2021092112130699000_ytab312-B7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000069777","article-title":"Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis","volume":"49","author":"Kocazeybek","year":"2003","journal-title":"Chemotherapy"},{"key":"2021092112130699000_ytab312-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/701480","article-title":"Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections","volume":"2015","author":"Leli","year":"2015","journal-title":"Dis Markers"},{"key":"2021092112130699000_ytab312-B9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.amjmed.2010.07.018","article-title":"Procalcitonin in 759 patients clinically suspected of infective endocarditis","volume":"123","author":"Knudsen","year":"2010","journal-title":"Am J Med"},{"key":"2021092112130699000_ytab312-B10","first-page":"1281","article-title":"Endocarditis sustained by Streptococcus viridans with normal levels of procalcitonin: an unexpected finding","volume":"21","author":"Merra","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"2021092112130699000_ytab312-B11","doi-asserted-by":"crossref","first-page":"e2264","DOI":"10.1097\/MD.0000000000002264","article-title":"Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study","volume":"96","author":"Laukemann","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2021092112130699000_ytab312-B12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-8703(94)90752-8","article-title":"Natural history of vegetations during successful medical treatment of endocarditis","volume":"128","author":"Vuille","year":"1994","journal-title":"Am Heart J"},{"key":"2021092112130699000_ytab312-B13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2334-13-272","article-title":"Inflammatory parameters and prediction of prognosis in infective endocarditis","volume":"13","author":"Cornelissen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2021092112130699000_ytab312-B14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2020.03.005","article-title":"Prognostic value of residual vegetation after antibiotic treatment for infective endocarditis: a retrospective cohort study","volume":"94","author":"Houard","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2021092112130699000_ytab312-B15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0735-1097(02)01790-4","article-title":"Risk of embolization after institution of antibiotic therapy for infective endocarditis","volume":"39","author":"Vilacosta","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytab312\/39541635\/ytab312.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/9\/ytab312\/40422427\/ytab312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/5\/9\/ytab312\/40422427\/ytab312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T12:15:54Z","timestamp":1632226554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytab312\/6335676"}},"subtitle":[],"editor":[{"given":"Rita","family":"Pavasini","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Faten","family":"Yahia","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Luca","family":"Arcari","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Matteo","family":"Parollo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Aiste","family":"Monika Jakstaite","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytab312","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,8,2]]},"article-number":"ytab312"}}